Tecoland is an Active Pharmaceutical Ingredients (APIs) supplier. With US FDA and European Health Authority (EMEA) approved cGMP facilities engaging in process development, organic synthesis manufacturing and fermentation production. Tecoland supplies high quality APIs to pharmaceutical industry and provides technical and regulatory support. All of our products are manufactured within the scope of existing patent laws.

Over the years, Tecoland has developed several cGMP API manufacturing facilities, which have been inspected and approved by US FDA, European Health Authority (EMEA), Japan Pharmaceuticals and Medical Devices Agency (PMDA), Australia Therapeutic Goods Administration (TGA) and United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA). Tecoland works closely with our customers on enhancing product development and obtaining approval from regulatory authorities. We supply pharmaceutical industry with reliable sources of high quality APIs at competitive prices.

Our goal is to partner with finished dosage pharmaceutical manufacturers and to grow with our partners through contributing to their success. Currently Tecoland is commercially supplying APIs to our customers in USA, Canada, Europe, Japan and Australia. Tecoland also successfully supports our customers in new drug development by providing high quality APIs, technical and regulatory support. Our customers are now using Tecoland's APIs in their phase I, II and III clinical trials.